Osteoporosis is a disease in which bone resorbs faster than it is formed, gradually weakening its structure over time and ...

One major contributor to osteoporosis is estrogen deficiency, which is prevalent in postmenopausal women. Estrogen plays a vital role in maintaining bone density by inhibiting bone resorption and ...

“Our findings suggest that injectable hydrogels with localized anti-catabolic drug delivery can complement systemic ...

commonly used to treat osteoporosis. Denosumab: A monoclonal antibody that inhibits bone resorption, used in the treatment of osteoporosis. Anabolic agents: Medications that stimulate bone ...

Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local increases in bone density. The results offer hope for future fracture ...

Osteoporosis associated with chronic glucocorticoid ... by stimulating the process of bone resorption and inhibiting bone formation. According to some authors, even small doses, such as <2.5 ...

One of only a handful of academic centers in the United States dedicated to skeletal health, the Johns Hopkins Metabolic Bone and Osteoporosis Center is committed to providing patients and their ...

Inhibiting bone resorption via an effect on the RANK/RANKL/OPG signaling pathway (see following section); Enhancing bone formation by prolonging the lifespan of osteoblast cells (Figure 1A).

Researchers have combined injections of a novel hydrogel with systemic osteoporosis drugs in rats, achieving rapid local ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...